BSPED2024 Poster Presentations Diabetes 2 (8 abstracts)
A review of screening tools for disordered eating in type 1 diabetes to inform the development of children and young peoples diabetes (CYPD) network guidelines
1Cardiff and Vale University Health Board, Cardiff, United Kingdom; 2Cardiff Metropolitan University, Cardiff, United Kingdom; 3Frimley Health NHS Foundation Trust, Frimley, United Kingdom; 4Cambridge University Hospitals NHS Trust, Cambridge, United Kingdom; 5Leeds Teaching Hospital NHS Trust, Leeds, United Kingdom; 6University Hospital Bristol and Weston, Bristol, United Kingdom; 7Gloucester Hospitals NHS Foundation Trust, Gloucester, United Kingdom; 8Hywel Dda University Health Board, Carmarthen, United Kingdom; 9Lewisham and Greenwich NHS Trust, London, United Kingdom; 10University Hospitals of Derby and Burton NHS Foundation Trust, Derby, United Kingdom; 11Gateshead Health NHS Foundation Trust, Gateshead, United Kingdom; 12King's College Hospital NHS Foundation Trust, London, United Kingdom
Introduction: The Type 1 Diabetes and Eating Difficulties/Disorders of Eating Network (T1DDEN) Task and Finish Group: Identification and Screening was established in December 2023 as part of an over-arching workstream to tackle eating difficulties and eating disorders in paediatric diabetes care. Pursey et al., 2020, revealed a wide variety of screening tools (n = 48), but a paucity of validated screening tools(n = 5) for Type 1 Diabetes.
The purpose of this professional groups rapid literature review was
1. Identify current screening tools available for use in paediatric diabetes care
2. Consider the practicality of use in clinical care, risks and cost for commonly used screening tools in clinical care.
Methods: A search of the literature up to February 2024 (CINAHL, Medline, Embase, Scopus) included three broad categories (Type 1 Diabetes, Eating, or feeding disorders and screening tools). Screening tool titles were extracted and the most frequently used screening tools identified for review.
Results: The search returned 263 papers (17 excluded). These were scanned for relevant screening tools. 102 screening tools had been used across all papers. There were no new published screening tools (since 2020). A summary of the most relevant and commonly used screening tools within the literature is shared in the below table. Translations were available for most screening tools.
Validated for diabetes | Cost | Practicality | Age | Risks | Who can screen | |
DEPS-R | Yes | Free | Short | 13+ | Leading questions around insulin restriction | All |
EDI - 3RC | Modified and original version show good internal reliability | £126 | Short | 13+ | Trained Health Professionals | |
SEEDS | Yes | Free | Short | 12+ | Does not include weight control behaviours | All |
EDE-QS | Modified and original version show good internal reliability | Free | High sensitivity, easy to use | 14+ (12+ available) | All | |
mSCOFF | Not against gold standard | Free | Very short but requires follow up interview | 12+ | High false positive | All (with training) |
EAT-26 | No but often used | Free (with permission) | Short | Adolescents + | Not validated for diabetes | Health Professionals only |
Discussion: There are a range of published screening tools that can be used in paediatric care. This will inform the development of CYPD Network guidelines. Further considerations younger people and cultural sensitivities are needed.